Own a Hedge Fund that is constantly looking for businesses that have great growth potential
Linked In Description:
Investment Banking for Tech companies in Enterprise and Consumer segments.
A veteran in Enterprise, Mobile and Digital Media, Corporate Development VR, Voice Powered AI, Smart Devices, Mobile Advertising, Gaming, Artificial Intelligence, and IoT. Extensive deal-making with Mobile Carriers, Major Brands, Media Companies, Advertisers, Enterprise Sales, and Business Development, OEM's, Internet of Things (IoT) and Venture Capital. Entrepreneur, Angel Investor.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
As a Partner at Greenspring Associates, I lead the firm’s Healthcare and Portfolio Impact teams although I act as a generalist. The Healthcare team is focused on venture fund, direct, & secondary investments. The Portfolio Impact team helps with targeted relationships with Corporates interested in innovation, venture funds, talent acquisition, & unique IT & HC events. At Greenspring, we invest in three distinct categories: venture funds of all stages, early and growth-stage companies alongside our managers, and secondary opportunities. Each investment category informs the other, helping us capture powerful data, all while furthering our goal of building trusted relationships with venture managers and founders. Our funds incorporate one or more investment categories, each optimized for clients’ specific objectives.Founded in 2000 to focus solely on venture capital investments, Greenspring Associates believes that deep relationships built on mutual trust lead to better returns. Our mission is to serve as a value-added, lifecycle partner for fund managers and entrepreneurs on both a primary and secondary basis. With a comprehensive investment platform, data analytics capabilities, and dedicated Portfolio Impact program, we manage over $11 billion in committed capital across diversified, direct, secondary, and bespoke venture strategies for a diverse group of institutions and high net worth individuals.
Investing in Software (Web Marketplace Saas..) &b... Beverly Hills Califor..., U.S.A. - U.K. - India
Beverly Hills California - London - New York City (NY) - Chicago Illinois - Bethesda Maryland - Indianapolis Indiana - Annapolis Maryland - Bellevue Washington - Houston Texas - Washington D.C - Indiana - Virginia - Texas - Illinois, U.S.A. - U.K. - India
Perseus is a merchant bank and private equity fund management company headquartered in Washington, D.C., with an office in New York and an associated advisory firm in Munich. Perseus has invested in numerous growth equity, turnaround, and buyout transactions in the United States, Canada, and Western Europe. Perseus manages seven private equity funds and makes control equity investments in middle market companies that offer opportunities for value creation and enhancement. Since its inception in 1995, Perseus has made investments in more than 60 portfolio companies in a wide variety of industries in which Perseus and its principals have expertise, including energy, environmental, and engineering technologies; healthcare; and branded consumer products. Perseus has raised more than $1.6 billion in capital commitments. Perseus Partners VII, L.P., which was established in 2006, is a $602 million fund focused on control investments in middle market growth equity transactions principally in the energy, environmental, and engineering technology, healthcare, and branded consumer products sectors. This fund has been fully committed or reserved. Perseus also co-manages a $449 million fund that invests exclusively in life sciences companies. Growth equity and turnaround investing have been core investment focuses of Perseus since inception, supplemented by occasional opportunistic leveraged buyouts when supported by appropriate market conditions.
• Confluence Life Sciences:
$2400000 (Later stage VC)
• Slate Bio:
$1750000 (Seed Round)
$500000 (Seed Round)
Edinburgh - Bethesda, Maryland, U.S.A.
BioTech • Medical Devices (& Hospital Services) • Investment Management • Life Science
Principal with Epidarex Capital; a transatlantic fund investing in early-stage, high growth life science companies in under-ventured markets within the UK and US. Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today’s healthcare market. I have extensive experience in the commercialisation of early-stage health science technologies. As a Business Manager with Medical Research Council Technology (MRCT) I was responsible for exploitation of intellectual property arising from a number of MRC Units. I previously worked with the Scottish Enterprise Proof of Concept Programme, building and funding spin-out companies from leading Scottish academic institutions. I have a Ph.D. in molecular biology from the University of Edinburgh.Specialties: Venture capital, due diligence, IP management market research, technology transfer